SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001104659-13-071425
Filing Date
2013-09-20
Accepted
2013-09-20 16:51:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 10-12G/A a13-20977_11012ga.htm 10-12G/A 46450
2 EX-10.4 a13-20977_1ex10d4.htm EX-10.4 454730
3 EX-99.1 a13-20977_1ex99d1.htm EX-99.1 1042137
  Complete submission text file 0001104659-13-071425.txt   1544319
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-12G/A | Act: 34 | File No.: 000-55020 | Film No.: 131108373
SIC: 2834 Pharmaceutical Preparations